This is an HTML version of an attachment to the Freedom of Information request 'Stakeholder contacts on TTIP (since 12 December 2014)'.



Ref. Ares(2015)5458190 - 30/11/2015
Ref. Ares(2017)3665978 - 20/07/2017
From: 
[Art. 4.1(b)]
Sent: 
23 November 2015 16:44 
To: 
ASENIUS Maria (CAB-MALMSTROM); CEBALLOS BARON Miguel (CAB-
MALMSTROM);  [Art. 4.1(b)]
 (TRADE);  [Art. 4.1(b)]
(TRADE);  [Art. 4.1(b)]  (TRADE); 
[Art. 4.1(b)]
 (TRADE);  [Art. 4.1(b)]
 (TRADE);  [Art. 4.1(b)]
 (TRADE);  [Art. 4.1(b)]
(TRADE); [Art. 4.1(b)]  (TRADE);  [Art. 4.1(b)]  (SANTE); [Art. 4.1(b)]
(TRADE); [Art. 4.1(b)]
 (TRADE);  [Art. 4.1(b)]  (TRADE); 
 (TRADE); 
 (TRADE) 
[Art. 4.1(b)]
[Art. 4.1(b)]
Subject: 
Report TRADE Cabinet- EFPIA Meeting 19/11/2015 
Dear colleagues, 
Please find below a report of the meeting Cabinet had with EFPIA last Thursday. 
Kind regards, 
[Art. 4.1(b)]
Cabinet – EFPIA board meeting, 19 November 2015 
Participants: Richard Bergström (DG EFPIA),  [Art. 4.1(b)]
,  [Art. 4.1(b)]
,  [Art. 4.1(b)]
  Mia Asenius (CAB), Miguel Ceballos Baron (CAB),  [Art. 4.1(b)]
EFPIA wanted to meet with the Cabinet of Commissioner Malmström to discuss their key priorities for 
(mainly) TTIP, CETA and China. 
TTIP  
CAB thanked EFPIA for their technical input since the beginning of the TTIP negotiations. EFPIA explained 
[Art.4.1(a) 
that their position is very much in line with the one of 
. For EFPIA TTIP is an opportunity to 
and 4.3]
[Art. 4.1(a) and 4.3]
. They  want  the  Commission  to  be  more  ambitious. 
[Art. 4.1(a) and 4.3]
, according to EFPIA, 
only a basic and obvious element of a future agreement. They want to see more ambition on 
[Art. 4.1(a) and 4.3]
 They also underlined that they do not ask for  [Art. 4.1(a) and 4.3]
 Another point of interest for EFPIA is 
[Art. 4.1(a) and 4.3]
 CAB agreed on the importance of  [Art. 4.1(a) and 4.3]
 for the pharmaceutical sector. Furthermore EFPIA 
pushed for a provision in the agreement  [Art. 4.1(a) and 4.3]

EFPIA also informed COM about an online dialogue on TTIP they had organised recently. During this 
event, CEO’s took the time to reply upon specific TTIP questions from the public and to clarify some 
unjustified concerns people have (e.g. Will TTIP lead to higher prices or lower standards for medicines?). 
EFPIA's advice to COM is to organise more outreach meetings to explain what is actually going on in the 
TTIP negotiations as there is a lot of false information circulating in the public atmosphere. 
[Out of scope]
[Art. 4.1(b)]
[Art. 4.1(b)]
[Art. 4.1(b)]

[Art. 4.1(b)]
B-1049 Brussels/Belgium 
[Art. 4.1(b)]
Useful links: 
More on EU trade policy  
Follow the EU's Trade Policy Team on Twitter